Global Allergy Immunotherapy Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Allergy Immunotherapy Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 94

Published Date: 18 Mar 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.

According to our (Global Info Research) latest study, the global Allergy Immunotherapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

In EMEA, Allergy Immunotherapy main players include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, Holister Stier, Leti, etc., totally accounting for about 98% of market. As for the types of products, it can be divided into Subcutaneous Immunotherapy and Sublingual Immunotherapy. The most common product is Subcutaneous Immunotherapy, with a share over 60%. In terms of applications, it is widely used in Allergic Rhinitis, Allergic Asthma and Others. The most application is in Allergic Rhinitis, with a share over 45%.

This report is a detailed and comprehensive analysis for global Allergy Immunotherapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Allergy Immunotherapy market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Allergy Immunotherapy market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Allergy Immunotherapy market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Allergy Immunotherapy market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Allergy Immunotherapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Allergy Immunotherapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics and HAL, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Allergy Immunotherapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy

Market segment by Application
Allergic Rhinitis
Allergic Asthma
Others

Major players covered
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
Holister Stier
Leti

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Allergy Immunotherapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Allergy Immunotherapy, with price, sales, revenue and global market share of Allergy Immunotherapy from 2018 to 2023.
Chapter 3, the Allergy Immunotherapy competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Allergy Immunotherapy breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Allergy Immunotherapy market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Allergy Immunotherapy.
Chapter 14 and 15, to describe Allergy Immunotherapy sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Allergy Immunotherapy
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Allergy Immunotherapy Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Subcutaneous Immunotherapy
1.3.3 Sublingual Immunotherapy
1.4 Market Analysis by Application
1.4.1 Overview: Global Allergy Immunotherapy Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Allergic Rhinitis
1.4.3 Allergic Asthma
1.4.4 Others
1.5 Global Allergy Immunotherapy Market Size & Forecast
1.5.1 Global Allergy Immunotherapy Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Allergy Immunotherapy Sales Quantity (2018-2029)
1.5.3 Global Allergy Immunotherapy Average Price (2018-2029)

2 Manufacturers Profiles
2.1 ALK-Abello
2.1.1 ALK-Abello Details
2.1.2 ALK-Abello Major Business
2.1.3 ALK-Abello Allergy Immunotherapy Product and Services
2.1.4 ALK-Abello Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 ALK-Abello Recent Developments/Updates
2.2 Stallergenes Greer
2.2.1 Stallergenes Greer Details
2.2.2 Stallergenes Greer Major Business
2.2.3 Stallergenes Greer Allergy Immunotherapy Product and Services
2.2.4 Stallergenes Greer Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Stallergenes Greer Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Allergy Immunotherapy Product and Services
2.3.4 Merck Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Merck Recent Developments/Updates
2.4 Allergy Therapeutics
2.4.1 Allergy Therapeutics Details
2.4.2 Allergy Therapeutics Major Business
2.4.3 Allergy Therapeutics Allergy Immunotherapy Product and Services
2.4.4 Allergy Therapeutics Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Allergy Therapeutics Recent Developments/Updates
2.5 HAL
2.5.1 HAL Details
2.5.2 HAL Major Business
2.5.3 HAL Allergy Immunotherapy Product and Services
2.5.4 HAL Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 HAL Recent Developments/Updates
2.6 Holister Stier
2.6.1 Holister Stier Details
2.6.2 Holister Stier Major Business
2.6.3 Holister Stier Allergy Immunotherapy Product and Services
2.6.4 Holister Stier Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Holister Stier Recent Developments/Updates
2.7 Leti
2.7.1 Leti Details
2.7.2 Leti Major Business
2.7.3 Leti Allergy Immunotherapy Product and Services
2.7.4 Leti Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Leti Recent Developments/Updates

3 Competitive Environment: Allergy Immunotherapy by Manufacturer
3.1 Global Allergy Immunotherapy Sales Quantity by Manufacturer (2018-2023)
3.2 Global Allergy Immunotherapy Revenue by Manufacturer (2018-2023)
3.3 Global Allergy Immunotherapy Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Allergy Immunotherapy by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Allergy Immunotherapy Manufacturer Market Share in 2022
3.4.2 Top 6 Allergy Immunotherapy Manufacturer Market Share in 2022
3.5 Allergy Immunotherapy Market: Overall Company Footprint Analysis
3.5.1 Allergy Immunotherapy Market: Region Footprint
3.5.2 Allergy Immunotherapy Market: Company Product Type Footprint
3.5.3 Allergy Immunotherapy Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Allergy Immunotherapy Market Size by Region
4.1.1 Global Allergy Immunotherapy Sales Quantity by Region (2018-2029)
4.1.2 Global Allergy Immunotherapy Consumption Value by Region (2018-2029)
4.1.3 Global Allergy Immunotherapy Average Price by Region (2018-2029)
4.2 North America Allergy Immunotherapy Consumption Value (2018-2029)
4.3 Europe Allergy Immunotherapy Consumption Value (2018-2029)
4.4 Asia-Pacific Allergy Immunotherapy Consumption Value (2018-2029)
4.5 South America Allergy Immunotherapy Consumption Value (2018-2029)
4.6 Middle East and Africa Allergy Immunotherapy Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Allergy Immunotherapy Sales Quantity by Type (2018-2029)
5.2 Global Allergy Immunotherapy Consumption Value by Type (2018-2029)
5.3 Global Allergy Immunotherapy Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Allergy Immunotherapy Sales Quantity by Application (2018-2029)
6.2 Global Allergy Immunotherapy Consumption Value by Application (2018-2029)
6.3 Global Allergy Immunotherapy Average Price by Application (2018-2029)

7 North America
7.1 North America Allergy Immunotherapy Sales Quantity by Type (2018-2029)
7.2 North America Allergy Immunotherapy Sales Quantity by Application (2018-2029)
7.3 North America Allergy Immunotherapy Market Size by Country
7.3.1 North America Allergy Immunotherapy Sales Quantity by Country (2018-2029)
7.3.2 North America Allergy Immunotherapy Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Allergy Immunotherapy Sales Quantity by Type (2018-2029)
8.2 Europe Allergy Immunotherapy Sales Quantity by Application (2018-2029)
8.3 Europe Allergy Immunotherapy Market Size by Country
8.3.1 Europe Allergy Immunotherapy Sales Quantity by Country (2018-2029)
8.3.2 Europe Allergy Immunotherapy Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Allergy Immunotherapy Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Allergy Immunotherapy Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Allergy Immunotherapy Market Size by Region
9.3.1 Asia-Pacific Allergy Immunotherapy Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Allergy Immunotherapy Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Allergy Immunotherapy Sales Quantity by Type (2018-2029)
10.2 South America Allergy Immunotherapy Sales Quantity by Application (2018-2029)
10.3 South America Allergy Immunotherapy Market Size by Country
10.3.1 South America Allergy Immunotherapy Sales Quantity by Country (2018-2029)
10.3.2 South America Allergy Immunotherapy Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Allergy Immunotherapy Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Allergy Immunotherapy Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Allergy Immunotherapy Market Size by Country
11.3.1 Middle East & Africa Allergy Immunotherapy Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Allergy Immunotherapy Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Allergy Immunotherapy Market Drivers
12.2 Allergy Immunotherapy Market Restraints
12.3 Allergy Immunotherapy Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Allergy Immunotherapy and Key Manufacturers
13.2 Manufacturing Costs Percentage of Allergy Immunotherapy
13.3 Allergy Immunotherapy Production Process
13.4 Allergy Immunotherapy Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Allergy Immunotherapy Typical Distributors
14.3 Allergy Immunotherapy Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Allergy Immunotherapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Allergy Immunotherapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. ALK-Abello Basic Information, Manufacturing Base and Competitors
Table 4. ALK-Abello Major Business
Table 5. ALK-Abello Allergy Immunotherapy Product and Services
Table 6. ALK-Abello Allergy Immunotherapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. ALK-Abello Recent Developments/Updates
Table 8. Stallergenes Greer Basic Information, Manufacturing Base and Competitors
Table 9. Stallergenes Greer Major Business
Table 10. Stallergenes Greer Allergy Immunotherapy Product and Services
Table 11. Stallergenes Greer Allergy Immunotherapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Stallergenes Greer Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Allergy Immunotherapy Product and Services
Table 16. Merck Allergy Immunotherapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Merck Recent Developments/Updates
Table 18. Allergy Therapeutics Basic Information, Manufacturing Base and Competitors
Table 19. Allergy Therapeutics Major Business
Table 20. Allergy Therapeutics Allergy Immunotherapy Product and Services
Table 21. Allergy Therapeutics Allergy Immunotherapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Allergy Therapeutics Recent Developments/Updates
Table 23. HAL Basic Information, Manufacturing Base and Competitors
Table 24. HAL Major Business
Table 25. HAL Allergy Immunotherapy Product and Services
Table 26. HAL Allergy Immunotherapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. HAL Recent Developments/Updates
Table 28. Holister Stier Basic Information, Manufacturing Base and Competitors
Table 29. Holister Stier Major Business
Table 30. Holister Stier Allergy Immunotherapy Product and Services
Table 31. Holister Stier Allergy Immunotherapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Holister Stier Recent Developments/Updates
Table 33. Leti Basic Information, Manufacturing Base and Competitors
Table 34. Leti Major Business
Table 35. Leti Allergy Immunotherapy Product and Services
Table 36. Leti Allergy Immunotherapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Leti Recent Developments/Updates
Table 38. Global Allergy Immunotherapy Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 39. Global Allergy Immunotherapy Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global Allergy Immunotherapy Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 41. Market Position of Manufacturers in Allergy Immunotherapy, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and Allergy Immunotherapy Production Site of Key Manufacturer
Table 43. Allergy Immunotherapy Market: Company Product Type Footprint
Table 44. Allergy Immunotherapy Market: Company Product Application Footprint
Table 45. Allergy Immunotherapy New Market Entrants and Barriers to Market Entry
Table 46. Allergy Immunotherapy Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Allergy Immunotherapy Sales Quantity by Region (2018-2023) & (K Units)
Table 48. Global Allergy Immunotherapy Sales Quantity by Region (2024-2029) & (K Units)
Table 49. Global Allergy Immunotherapy Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global Allergy Immunotherapy Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global Allergy Immunotherapy Average Price by Region (2018-2023) & (USD/Unit)
Table 52. Global Allergy Immunotherapy Average Price by Region (2024-2029) & (USD/Unit)
Table 53. Global Allergy Immunotherapy Sales Quantity by Type (2018-2023) & (K Units)
Table 54. Global Allergy Immunotherapy Sales Quantity by Type (2024-2029) & (K Units)
Table 55. Global Allergy Immunotherapy Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global Allergy Immunotherapy Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global Allergy Immunotherapy Average Price by Type (2018-2023) & (USD/Unit)
Table 58. Global Allergy Immunotherapy Average Price by Type (2024-2029) & (USD/Unit)
Table 59. Global Allergy Immunotherapy Sales Quantity by Application (2018-2023) & (K Units)
Table 60. Global Allergy Immunotherapy Sales Quantity by Application (2024-2029) & (K Units)
Table 61. Global Allergy Immunotherapy Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global Allergy Immunotherapy Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global Allergy Immunotherapy Average Price by Application (2018-2023) & (USD/Unit)
Table 64. Global Allergy Immunotherapy Average Price by Application (2024-2029) & (USD/Unit)
Table 65. North America Allergy Immunotherapy Sales Quantity by Type (2018-2023) & (K Units)
Table 66. North America Allergy Immunotherapy Sales Quantity by Type (2024-2029) & (K Units)
Table 67. North America Allergy Immunotherapy Sales Quantity by Application (2018-2023) & (K Units)
Table 68. North America Allergy Immunotherapy Sales Quantity by Application (2024-2029) & (K Units)
Table 69. North America Allergy Immunotherapy Sales Quantity by Country (2018-2023) & (K Units)
Table 70. North America Allergy Immunotherapy Sales Quantity by Country (2024-2029) & (K Units)
Table 71. North America Allergy Immunotherapy Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America Allergy Immunotherapy Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe Allergy Immunotherapy Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Europe Allergy Immunotherapy Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Europe Allergy Immunotherapy Sales Quantity by Application (2018-2023) & (K Units)
Table 76. Europe Allergy Immunotherapy Sales Quantity by Application (2024-2029) & (K Units)
Table 77. Europe Allergy Immunotherapy Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe Allergy Immunotherapy Sales Quantity by Country (2024-2029) & (K Units)
Table 79. Europe Allergy Immunotherapy Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Allergy Immunotherapy Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Allergy Immunotherapy Sales Quantity by Type (2018-2023) & (K Units)
Table 82. Asia-Pacific Allergy Immunotherapy Sales Quantity by Type (2024-2029) & (K Units)
Table 83. Asia-Pacific Allergy Immunotherapy Sales Quantity by Application (2018-2023) & (K Units)
Table 84. Asia-Pacific Allergy Immunotherapy Sales Quantity by Application (2024-2029) & (K Units)
Table 85. Asia-Pacific Allergy Immunotherapy Sales Quantity by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific Allergy Immunotherapy Sales Quantity by Region (2024-2029) & (K Units)
Table 87. Asia-Pacific Allergy Immunotherapy Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific Allergy Immunotherapy Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America Allergy Immunotherapy Sales Quantity by Type (2018-2023) & (K Units)
Table 90. South America Allergy Immunotherapy Sales Quantity by Type (2024-2029) & (K Units)
Table 91. South America Allergy Immunotherapy Sales Quantity by Application (2018-2023) & (K Units)
Table 92. South America Allergy Immunotherapy Sales Quantity by Application (2024-2029) & (K Units)
Table 93. South America Allergy Immunotherapy Sales Quantity by Country (2018-2023) & (K Units)
Table 94. South America Allergy Immunotherapy Sales Quantity by Country (2024-2029) & (K Units)
Table 95. South America Allergy Immunotherapy Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America Allergy Immunotherapy Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa Allergy Immunotherapy Sales Quantity by Type (2018-2023) & (K Units)
Table 98. Middle East & Africa Allergy Immunotherapy Sales Quantity by Type (2024-2029) & (K Units)
Table 99. Middle East & Africa Allergy Immunotherapy Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Middle East & Africa Allergy Immunotherapy Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Middle East & Africa Allergy Immunotherapy Sales Quantity by Region (2018-2023) & (K Units)
Table 102. Middle East & Africa Allergy Immunotherapy Sales Quantity by Region (2024-2029) & (K Units)
Table 103. Middle East & Africa Allergy Immunotherapy Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa Allergy Immunotherapy Consumption Value by Region (2024-2029) & (USD Million)
Table 105. Allergy Immunotherapy Raw Material
Table 106. Key Manufacturers of Allergy Immunotherapy Raw Materials
Table 107. Allergy Immunotherapy Typical Distributors
Table 108. Allergy Immunotherapy Typical Customers
List of Figures
Figure 1. Allergy Immunotherapy Picture
Figure 2. Global Allergy Immunotherapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Allergy Immunotherapy Consumption Value Market Share by Type in 2022
Figure 4. Subcutaneous Immunotherapy Examples
Figure 5. Sublingual Immunotherapy Examples
Figure 6. Global Allergy Immunotherapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Allergy Immunotherapy Consumption Value Market Share by Application in 2022
Figure 8. Allergic Rhinitis Examples
Figure 9. Allergic Asthma Examples
Figure 10. Others Examples
Figure 11. Global Allergy Immunotherapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Allergy Immunotherapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Allergy Immunotherapy Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Allergy Immunotherapy Average Price (2018-2029) & (USD/Unit)
Figure 15. Global Allergy Immunotherapy Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Allergy Immunotherapy Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Allergy Immunotherapy by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Allergy Immunotherapy Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Allergy Immunotherapy Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Allergy Immunotherapy Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Allergy Immunotherapy Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Allergy Immunotherapy Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Allergy Immunotherapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Allergy Immunotherapy Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Allergy Immunotherapy Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Allergy Immunotherapy Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Allergy Immunotherapy Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Allergy Immunotherapy Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Allergy Immunotherapy Average Price by Type (2018-2029) & (USD/Unit)
Figure 30. Global Allergy Immunotherapy Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Allergy Immunotherapy Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Allergy Immunotherapy Average Price by Application (2018-2029) & (USD/Unit)
Figure 33. North America Allergy Immunotherapy Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Allergy Immunotherapy Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Allergy Immunotherapy Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Allergy Immunotherapy Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Allergy Immunotherapy Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Allergy Immunotherapy Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Allergy Immunotherapy Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Allergy Immunotherapy Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Allergy Immunotherapy Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Allergy Immunotherapy Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Allergy Immunotherapy Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Allergy Immunotherapy Consumption Value Market Share by Region (2018-2029)
Figure 53. China Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Allergy Immunotherapy Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Allergy Immunotherapy Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Allergy Immunotherapy Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Allergy Immunotherapy Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Allergy Immunotherapy Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Allergy Immunotherapy Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Allergy Immunotherapy Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Allergy Immunotherapy Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Allergy Immunotherapy Market Drivers
Figure 74. Allergy Immunotherapy Market Restraints
Figure 75. Allergy Immunotherapy Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Allergy Immunotherapy in 2022
Figure 78. Manufacturing Process Analysis of Allergy Immunotherapy
Figure 79. Allergy Immunotherapy Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Allergy Immunotherapy Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Allergy Immunotherapy Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 94

Published Date: 18 Mar 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.

According to our (Global Info Research) latest study, the global Allergy Immunotherapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

In EMEA, Allergy Immunotherapy main players include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, Holister Stier, Leti, etc., totally accounting for about 98% of market. As for the types of products, it can be divided into Subcutaneous Immunotherapy and Sublingual Immunotherapy. The most common product is Subcutaneous Immunotherapy, with a share over 60%. In terms of applications, it is widely used in Allergic Rhinitis, Allergic Asthma and Others. The most application is in Allergic Rhinitis, with a share over 45%.

This report is a detailed and comprehensive analysis for global Allergy Immunotherapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Allergy Immunotherapy market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Allergy Immunotherapy market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Allergy Immunotherapy market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Allergy Immunotherapy market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Allergy Immunotherapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Allergy Immunotherapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics and HAL, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Allergy Immunotherapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy

Market segment by Application
Allergic Rhinitis
Allergic Asthma
Others

Major players covered
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
Holister Stier
Leti

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Allergy Immunotherapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Allergy Immunotherapy, with price, sales, revenue and global market share of Allergy Immunotherapy from 2018 to 2023.
Chapter 3, the Allergy Immunotherapy competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Allergy Immunotherapy breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Allergy Immunotherapy market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Allergy Immunotherapy.
Chapter 14 and 15, to describe Allergy Immunotherapy sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Allergy Immunotherapy
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Allergy Immunotherapy Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Subcutaneous Immunotherapy
1.3.3 Sublingual Immunotherapy
1.4 Market Analysis by Application
1.4.1 Overview: Global Allergy Immunotherapy Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Allergic Rhinitis
1.4.3 Allergic Asthma
1.4.4 Others
1.5 Global Allergy Immunotherapy Market Size & Forecast
1.5.1 Global Allergy Immunotherapy Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Allergy Immunotherapy Sales Quantity (2018-2029)
1.5.3 Global Allergy Immunotherapy Average Price (2018-2029)

2 Manufacturers Profiles
2.1 ALK-Abello
2.1.1 ALK-Abello Details
2.1.2 ALK-Abello Major Business
2.1.3 ALK-Abello Allergy Immunotherapy Product and Services
2.1.4 ALK-Abello Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 ALK-Abello Recent Developments/Updates
2.2 Stallergenes Greer
2.2.1 Stallergenes Greer Details
2.2.2 Stallergenes Greer Major Business
2.2.3 Stallergenes Greer Allergy Immunotherapy Product and Services
2.2.4 Stallergenes Greer Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Stallergenes Greer Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Allergy Immunotherapy Product and Services
2.3.4 Merck Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Merck Recent Developments/Updates
2.4 Allergy Therapeutics
2.4.1 Allergy Therapeutics Details
2.4.2 Allergy Therapeutics Major Business
2.4.3 Allergy Therapeutics Allergy Immunotherapy Product and Services
2.4.4 Allergy Therapeutics Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Allergy Therapeutics Recent Developments/Updates
2.5 HAL
2.5.1 HAL Details
2.5.2 HAL Major Business
2.5.3 HAL Allergy Immunotherapy Product and Services
2.5.4 HAL Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 HAL Recent Developments/Updates
2.6 Holister Stier
2.6.1 Holister Stier Details
2.6.2 Holister Stier Major Business
2.6.3 Holister Stier Allergy Immunotherapy Product and Services
2.6.4 Holister Stier Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Holister Stier Recent Developments/Updates
2.7 Leti
2.7.1 Leti Details
2.7.2 Leti Major Business
2.7.3 Leti Allergy Immunotherapy Product and Services
2.7.4 Leti Allergy Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Leti Recent Developments/Updates

3 Competitive Environment: Allergy Immunotherapy by Manufacturer
3.1 Global Allergy Immunotherapy Sales Quantity by Manufacturer (2018-2023)
3.2 Global Allergy Immunotherapy Revenue by Manufacturer (2018-2023)
3.3 Global Allergy Immunotherapy Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Allergy Immunotherapy by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Allergy Immunotherapy Manufacturer Market Share in 2022
3.4.2 Top 6 Allergy Immunotherapy Manufacturer Market Share in 2022
3.5 Allergy Immunotherapy Market: Overall Company Footprint Analysis
3.5.1 Allergy Immunotherapy Market: Region Footprint
3.5.2 Allergy Immunotherapy Market: Company Product Type Footprint
3.5.3 Allergy Immunotherapy Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Allergy Immunotherapy Market Size by Region
4.1.1 Global Allergy Immunotherapy Sales Quantity by Region (2018-2029)
4.1.2 Global Allergy Immunotherapy Consumption Value by Region (2018-2029)
4.1.3 Global Allergy Immunotherapy Average Price by Region (2018-2029)
4.2 North America Allergy Immunotherapy Consumption Value (2018-2029)
4.3 Europe Allergy Immunotherapy Consumption Value (2018-2029)
4.4 Asia-Pacific Allergy Immunotherapy Consumption Value (2018-2029)
4.5 South America Allergy Immunotherapy Consumption Value (2018-2029)
4.6 Middle East and Africa Allergy Immunotherapy Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Allergy Immunotherapy Sales Quantity by Type (2018-2029)
5.2 Global Allergy Immunotherapy Consumption Value by Type (2018-2029)
5.3 Global Allergy Immunotherapy Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Allergy Immunotherapy Sales Quantity by Application (2018-2029)
6.2 Global Allergy Immunotherapy Consumption Value by Application (2018-2029)
6.3 Global Allergy Immunotherapy Average Price by Application (2018-2029)

7 North America
7.1 North America Allergy Immunotherapy Sales Quantity by Type (2018-2029)
7.2 North America Allergy Immunotherapy Sales Quantity by Application (2018-2029)
7.3 North America Allergy Immunotherapy Market Size by Country
7.3.1 North America Allergy Immunotherapy Sales Quantity by Country (2018-2029)
7.3.2 North America Allergy Immunotherapy Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Allergy Immunotherapy Sales Quantity by Type (2018-2029)
8.2 Europe Allergy Immunotherapy Sales Quantity by Application (2018-2029)
8.3 Europe Allergy Immunotherapy Market Size by Country
8.3.1 Europe Allergy Immunotherapy Sales Quantity by Country (2018-2029)
8.3.2 Europe Allergy Immunotherapy Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Allergy Immunotherapy Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Allergy Immunotherapy Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Allergy Immunotherapy Market Size by Region
9.3.1 Asia-Pacific Allergy Immunotherapy Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Allergy Immunotherapy Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Allergy Immunotherapy Sales Quantity by Type (2018-2029)
10.2 South America Allergy Immunotherapy Sales Quantity by Application (2018-2029)
10.3 South America Allergy Immunotherapy Market Size by Country
10.3.1 South America Allergy Immunotherapy Sales Quantity by Country (2018-2029)
10.3.2 South America Allergy Immunotherapy Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Allergy Immunotherapy Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Allergy Immunotherapy Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Allergy Immunotherapy Market Size by Country
11.3.1 Middle East & Africa Allergy Immunotherapy Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Allergy Immunotherapy Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Allergy Immunotherapy Market Drivers
12.2 Allergy Immunotherapy Market Restraints
12.3 Allergy Immunotherapy Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Allergy Immunotherapy and Key Manufacturers
13.2 Manufacturing Costs Percentage of Allergy Immunotherapy
13.3 Allergy Immunotherapy Production Process
13.4 Allergy Immunotherapy Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Allergy Immunotherapy Typical Distributors
14.3 Allergy Immunotherapy Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Allergy Immunotherapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Allergy Immunotherapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. ALK-Abello Basic Information, Manufacturing Base and Competitors
Table 4. ALK-Abello Major Business
Table 5. ALK-Abello Allergy Immunotherapy Product and Services
Table 6. ALK-Abello Allergy Immunotherapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. ALK-Abello Recent Developments/Updates
Table 8. Stallergenes Greer Basic Information, Manufacturing Base and Competitors
Table 9. Stallergenes Greer Major Business
Table 10. Stallergenes Greer Allergy Immunotherapy Product and Services
Table 11. Stallergenes Greer Allergy Immunotherapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Stallergenes Greer Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Allergy Immunotherapy Product and Services
Table 16. Merck Allergy Immunotherapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Merck Recent Developments/Updates
Table 18. Allergy Therapeutics Basic Information, Manufacturing Base and Competitors
Table 19. Allergy Therapeutics Major Business
Table 20. Allergy Therapeutics Allergy Immunotherapy Product and Services
Table 21. Allergy Therapeutics Allergy Immunotherapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Allergy Therapeutics Recent Developments/Updates
Table 23. HAL Basic Information, Manufacturing Base and Competitors
Table 24. HAL Major Business
Table 25. HAL Allergy Immunotherapy Product and Services
Table 26. HAL Allergy Immunotherapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. HAL Recent Developments/Updates
Table 28. Holister Stier Basic Information, Manufacturing Base and Competitors
Table 29. Holister Stier Major Business
Table 30. Holister Stier Allergy Immunotherapy Product and Services
Table 31. Holister Stier Allergy Immunotherapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Holister Stier Recent Developments/Updates
Table 33. Leti Basic Information, Manufacturing Base and Competitors
Table 34. Leti Major Business
Table 35. Leti Allergy Immunotherapy Product and Services
Table 36. Leti Allergy Immunotherapy Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Leti Recent Developments/Updates
Table 38. Global Allergy Immunotherapy Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 39. Global Allergy Immunotherapy Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global Allergy Immunotherapy Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 41. Market Position of Manufacturers in Allergy Immunotherapy, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and Allergy Immunotherapy Production Site of Key Manufacturer
Table 43. Allergy Immunotherapy Market: Company Product Type Footprint
Table 44. Allergy Immunotherapy Market: Company Product Application Footprint
Table 45. Allergy Immunotherapy New Market Entrants and Barriers to Market Entry
Table 46. Allergy Immunotherapy Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Allergy Immunotherapy Sales Quantity by Region (2018-2023) & (K Units)
Table 48. Global Allergy Immunotherapy Sales Quantity by Region (2024-2029) & (K Units)
Table 49. Global Allergy Immunotherapy Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global Allergy Immunotherapy Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global Allergy Immunotherapy Average Price by Region (2018-2023) & (USD/Unit)
Table 52. Global Allergy Immunotherapy Average Price by Region (2024-2029) & (USD/Unit)
Table 53. Global Allergy Immunotherapy Sales Quantity by Type (2018-2023) & (K Units)
Table 54. Global Allergy Immunotherapy Sales Quantity by Type (2024-2029) & (K Units)
Table 55. Global Allergy Immunotherapy Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global Allergy Immunotherapy Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global Allergy Immunotherapy Average Price by Type (2018-2023) & (USD/Unit)
Table 58. Global Allergy Immunotherapy Average Price by Type (2024-2029) & (USD/Unit)
Table 59. Global Allergy Immunotherapy Sales Quantity by Application (2018-2023) & (K Units)
Table 60. Global Allergy Immunotherapy Sales Quantity by Application (2024-2029) & (K Units)
Table 61. Global Allergy Immunotherapy Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global Allergy Immunotherapy Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global Allergy Immunotherapy Average Price by Application (2018-2023) & (USD/Unit)
Table 64. Global Allergy Immunotherapy Average Price by Application (2024-2029) & (USD/Unit)
Table 65. North America Allergy Immunotherapy Sales Quantity by Type (2018-2023) & (K Units)
Table 66. North America Allergy Immunotherapy Sales Quantity by Type (2024-2029) & (K Units)
Table 67. North America Allergy Immunotherapy Sales Quantity by Application (2018-2023) & (K Units)
Table 68. North America Allergy Immunotherapy Sales Quantity by Application (2024-2029) & (K Units)
Table 69. North America Allergy Immunotherapy Sales Quantity by Country (2018-2023) & (K Units)
Table 70. North America Allergy Immunotherapy Sales Quantity by Country (2024-2029) & (K Units)
Table 71. North America Allergy Immunotherapy Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America Allergy Immunotherapy Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe Allergy Immunotherapy Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Europe Allergy Immunotherapy Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Europe Allergy Immunotherapy Sales Quantity by Application (2018-2023) & (K Units)
Table 76. Europe Allergy Immunotherapy Sales Quantity by Application (2024-2029) & (K Units)
Table 77. Europe Allergy Immunotherapy Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe Allergy Immunotherapy Sales Quantity by Country (2024-2029) & (K Units)
Table 79. Europe Allergy Immunotherapy Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Allergy Immunotherapy Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Allergy Immunotherapy Sales Quantity by Type (2018-2023) & (K Units)
Table 82. Asia-Pacific Allergy Immunotherapy Sales Quantity by Type (2024-2029) & (K Units)
Table 83. Asia-Pacific Allergy Immunotherapy Sales Quantity by Application (2018-2023) & (K Units)
Table 84. Asia-Pacific Allergy Immunotherapy Sales Quantity by Application (2024-2029) & (K Units)
Table 85. Asia-Pacific Allergy Immunotherapy Sales Quantity by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific Allergy Immunotherapy Sales Quantity by Region (2024-2029) & (K Units)
Table 87. Asia-Pacific Allergy Immunotherapy Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific Allergy Immunotherapy Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America Allergy Immunotherapy Sales Quantity by Type (2018-2023) & (K Units)
Table 90. South America Allergy Immunotherapy Sales Quantity by Type (2024-2029) & (K Units)
Table 91. South America Allergy Immunotherapy Sales Quantity by Application (2018-2023) & (K Units)
Table 92. South America Allergy Immunotherapy Sales Quantity by Application (2024-2029) & (K Units)
Table 93. South America Allergy Immunotherapy Sales Quantity by Country (2018-2023) & (K Units)
Table 94. South America Allergy Immunotherapy Sales Quantity by Country (2024-2029) & (K Units)
Table 95. South America Allergy Immunotherapy Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America Allergy Immunotherapy Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa Allergy Immunotherapy Sales Quantity by Type (2018-2023) & (K Units)
Table 98. Middle East & Africa Allergy Immunotherapy Sales Quantity by Type (2024-2029) & (K Units)
Table 99. Middle East & Africa Allergy Immunotherapy Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Middle East & Africa Allergy Immunotherapy Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Middle East & Africa Allergy Immunotherapy Sales Quantity by Region (2018-2023) & (K Units)
Table 102. Middle East & Africa Allergy Immunotherapy Sales Quantity by Region (2024-2029) & (K Units)
Table 103. Middle East & Africa Allergy Immunotherapy Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa Allergy Immunotherapy Consumption Value by Region (2024-2029) & (USD Million)
Table 105. Allergy Immunotherapy Raw Material
Table 106. Key Manufacturers of Allergy Immunotherapy Raw Materials
Table 107. Allergy Immunotherapy Typical Distributors
Table 108. Allergy Immunotherapy Typical Customers
List of Figures
Figure 1. Allergy Immunotherapy Picture
Figure 2. Global Allergy Immunotherapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Allergy Immunotherapy Consumption Value Market Share by Type in 2022
Figure 4. Subcutaneous Immunotherapy Examples
Figure 5. Sublingual Immunotherapy Examples
Figure 6. Global Allergy Immunotherapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Allergy Immunotherapy Consumption Value Market Share by Application in 2022
Figure 8. Allergic Rhinitis Examples
Figure 9. Allergic Asthma Examples
Figure 10. Others Examples
Figure 11. Global Allergy Immunotherapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Allergy Immunotherapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Allergy Immunotherapy Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Allergy Immunotherapy Average Price (2018-2029) & (USD/Unit)
Figure 15. Global Allergy Immunotherapy Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Allergy Immunotherapy Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Allergy Immunotherapy by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Allergy Immunotherapy Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Allergy Immunotherapy Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Allergy Immunotherapy Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Allergy Immunotherapy Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Allergy Immunotherapy Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Allergy Immunotherapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Allergy Immunotherapy Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Allergy Immunotherapy Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Allergy Immunotherapy Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Allergy Immunotherapy Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Allergy Immunotherapy Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Allergy Immunotherapy Average Price by Type (2018-2029) & (USD/Unit)
Figure 30. Global Allergy Immunotherapy Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Allergy Immunotherapy Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Allergy Immunotherapy Average Price by Application (2018-2029) & (USD/Unit)
Figure 33. North America Allergy Immunotherapy Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Allergy Immunotherapy Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Allergy Immunotherapy Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Allergy Immunotherapy Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Allergy Immunotherapy Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Allergy Immunotherapy Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Allergy Immunotherapy Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Allergy Immunotherapy Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Allergy Immunotherapy Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Allergy Immunotherapy Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Allergy Immunotherapy Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Allergy Immunotherapy Consumption Value Market Share by Region (2018-2029)
Figure 53. China Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Allergy Immunotherapy Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Allergy Immunotherapy Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Allergy Immunotherapy Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Allergy Immunotherapy Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Allergy Immunotherapy Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Allergy Immunotherapy Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Allergy Immunotherapy Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Allergy Immunotherapy Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Allergy Immunotherapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Allergy Immunotherapy Market Drivers
Figure 74. Allergy Immunotherapy Market Restraints
Figure 75. Allergy Immunotherapy Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Allergy Immunotherapy in 2022
Figure 78. Manufacturing Process Analysis of Allergy Immunotherapy
Figure 79. Allergy Immunotherapy Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now